Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder

NCT02351869 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT02351869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2015
Completion date
June 7, 2020
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder